Bluebird Beats Patent Case Over Blood Disease Therapies

By Theresa Schliep · May 19, 2025, 7:43 PM EDT

A Delaware federal judge has tossed a lawsuit against Bluebird Bio alleging two of its multimillion-dollar gene therapy treatments for blood disorders infringed patents held by San Rocco Therapeutics LLC, after...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

San Rocco Therapeutics, LLC v. Bluebird Bio, Inc., et al.

Case Number

1:21-cv-01478

Court

Delaware

Nature of Suit

Patent

Date Filed

October 21, 2021